Commentary Open Access
Volume 2 | Issue 2 | DOI: https://doi.org/10.46439/Neuroscience.2.015
The protective role of dimethyltryptamine and its analogues against ischemia-reperfusion injury: Commentary
Ede Frecska1,*, Attila Kovacs1
- 1Psychiatry Clinic, University of Debrecen, Debrecen, Hungary
Corresponding Author
Ede Frecska, frecska.ede@med.unideb.hu
Received Date: August 22, 2021
Accepted Date: September 15, 2021
Frecska E, Kovacs A. The protective role of dimethyltryptamine and its analogues against ischemiareperfusion injury: Commentary. Neurosci Chron 2021; 2(2):39-42.
Copyright: © 2021 Frecska E, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Interhemispheric Asymmetry in the Pool of Amino Acids during Subtotal Cerebral Ischemia
Stroke is among the leading causes of disability and mortality in many countries of the world. The pathogenic mechanisms of ischemic stroke are very complex and have not been completely understood. The aim of this study was to estimate the amino acid (AA) pool in the brain hemisphere cortex of rats during Subtotal Cerebral Ischemia (SCI).
The protective role of dimethyltryptamine and its analogues against ischemia-reperfusion injury: Commentary
The article entitled “N,N-Dimethyltryptamine [DMT] attenuates spreading depolarization and restrains neurodegeneration by sigma-1 receptor activation in the ischemic rat brain” by Szabo et al. published recently in Neuropharmacology [1] is the last one in the series of studies on the potential benefits of DMT administration in different clinical forms of ischemia-reperfusion injury (IRI). The larger scope of the project – initiated and organized by Ede Frecska – is to collect support for a hypothesized biological function of this and related endogenous hallucinogen compounds such as 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT), 5-hydroxy-N,N-dimethyl-tryptamine (bufotenine) [2].
ST-segment elevation myocardial infarction and reperfusion therapy in the COVID-19 pandemic
The coronavirus disease 2019 (COVID-19) pandemic has been placing enormous pressure on global healthcare systems. Considerable resource allocation to the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, although fully inevitable, originated remarkable constraints in the access of patients with other diseases – in fact, elective admissions and nonurgent procedures or interventions were mostly canceled or deferred worldwide.
The beneficial role of vitamin B12 in injury induced by ischemia/reperfusion: beyond scavenging superoxide?
Vitamin B12 is one of the most complex non-protein compounds as described by Dorothy Hodgkin, a Nobel Prize-winning chemist, who discovered the molecular crystal structure of B12. Cobalamins (vitamin B12 derivatives) contain the rare transition metal, cobalt (Co), positioned in the center of a corrin ring and weakly bound to carbon. While cobalamins are synthesized only in certain bacteria and archaea, not in mice or humans, they are co-enzymes essential for all life except for plants. For example, in higher vertebrates, methyl-cobalamin and 5’-deoxyadenosyl-cobalamin are essential for the function of methionine synthase and methylmalonyl CoA mutase, respectively.